Todd Bauer, MD is an oncologist and associate director of drug development at the Sarah Cannon Research Institute at Tennessee Oncology in Nashville, Tenn. He specializes in adult malignancies, including lung, breast, and gastrointestinal, as well as serves as principle investigator on phase I clinical trials. He consults on molecular results and available clinical trials based on those results, as well as emerging technologies in the personalized medicine field.
Dr. Bauer has served as the principle investigator on numerous studies and has been involved in the development of some exciting agents. While he is proud of his involvement in those drugs, and all those that he has helped develop, his true passion is patient care. He spends much of his time practicing general medical oncology and hematology, caring for his patients on a one-on-one basis. He also enjoys helping educate colleagues about new and emerging paradigms of care in the oncology world.
Dr. Bauer holds a board certification in medical oncology. He earned his medical degree at Loyola University, his residency at Vanderbilt University, and his fellowship at The Ohio State University.